Results 21 to 30 of about 68,932 (288)

Peripheral and central mechanisms involved in hormonal control of male and female reproduction [PDF]

open access: yes, 2016
Reproduction involves the integration of hormonal signals acting across multiple systems togenerate a synchronized physiological output. A critical component of reproduction is the luteinizinghormone (LH) surge, which is mediated by estradiol (E2) and ...
Bentley, G. E.   +6 more
core   +1 more source

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty

open access: yesJCRPE, 2021
Objective:A consensus on how to monitor girls with central precocious puberty (CPP) during gonadotropin-releasing hormone agonist (GnRHa) treatment is lacking.
Stefanie Schubert   +4 more
doaj   +1 more source

Pregnancy Outcomes of Different Endometrial Preparation in Patients With a History of Cesarean Section

open access: yesFrontiers in Endocrinology, 2022
ObjectiveTo investigate the efficacies of three cycle regimens in women receiving frozen embryo transfer with a history of cesarean section: natural cycle treatment, hormone replacement therapy and treatment with gonadotropin-releasing hormone agonist ...
Run Xin Gan   +12 more
doaj   +1 more source

A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer [PDF]

open access: yes, 2016
Our aim was to systematically evaluate the benefits of degarelix as antagonist versus agonists of gonadotropin-releasing hormones (GnRH) for the treatment of advanced prostate cancer (PC).
CATTARINO, SUSANNA   +10 more
core   +1 more source

Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve

open access: yesReproductive Biology and Endocrinology, 2019
BackgroundDiminished ovarian reserve (DOR) remains one of the greatest obstacles affecting the chance of a successful live birth after fertility treatment.
Ming‐Huei Lin   +5 more
semanticscholar   +1 more source

Parathyroid localization [PDF]

open access: yes, 1986
Twenty-nine consecutive patients with suspected primary hyperparathyroidism were examined preoperatively using ultrasound, sonographically guided fine needle aspiration, and aspirate immunostaining for PTH.
Borisch, B.   +7 more
core   +1 more source

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review

open access: yesClinical Medicine Insights: Reproductive Health, 2019
The use of chemotherapy in premenopausal cancer patients may lead to chemotherapy-induced premature ovarian failure. Pharmacological temporary ovarian suppression obtained with the gonadotropin-releasing hormone agonist (GnRHa) administered concomitantly
F. Poggio   +10 more
semanticscholar   +1 more source

pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer

open access: yesEndocrine Connections, 2019
Estradiol is a key factor for tumorigenesis and prognosis of hormone receptor-positive breast cancer. Adipocytes are one source of estradiol in patients with breast cancer. Recent studies have shown that phosphorylated ribosomal protein S6 kinase-1 plays
Chan Sub Park   +8 more
doaj   +1 more source

Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction [PDF]

open access: yes, 2015
Peer reviewedPublisher ...
Basios, George   +4 more
core   +1 more source

GnRH agonist as a luteal support in IVF cycle: mini-review—is there a role?

open access: yesMiddle East Fertility Society Journal, 2022
Background It has been established that assisted reproductive technology (ART) cycles are usually accompanied by a defective luteal phase, and that luteal phase support (LPS) is mandatory to improve reproductive outcomes.
Hasan Maghraby   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy